These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14505678)

  • 21. Identification of a potent and nonpeptidyl ccr3 antagonist.
    Saeki T; Ohwaki K; Naya A; Kobayashi K; Ishikawa M; Ohtake N; Noguchi K
    Biochem Biophys Res Commun; 2001 Mar; 281(3):779-82. PubMed ID: 11237726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.
    Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Sudo M; Tsutsumi T; Endo N; Muroga Y; Hada T; Tanaka H; Morita T; Greene J; Barnum D; Saunders J; Kato Y; Myers PL; Tarby CM
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5413-6. PubMed ID: 15454236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists.
    Witherington J; Bordas V; Cooper DG; Forbes IT; Gribble AD; Ife RJ; Berkhout T; Gohil J; Groot PH
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2177-80. PubMed ID: 11514164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of small-molecule antagonists of chemokine receptors: screening strategy and assays.
    Fuentes ME
    Methods Mol Biol; 2004; 239():181-8. PubMed ID: 14573918
    [No Abstract]   [Full Text] [Related]  

  • 25. Design, synthesis, and discovery of a novel CCR1 antagonist.
    Naya A; Sagara Y; Ohwaki K; Saeki T; Ichikawa D; Iwasawa Y; Noguchi K; Ohtake N
    J Med Chem; 2001 Apr; 44(9):1429-35. PubMed ID: 11311066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Hamada N; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Jan; 16(1):144-56. PubMed ID: 17951061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
    Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
    Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in CCR3 antagonists.
    De Lucca GV
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):516-24. PubMed ID: 16889234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists.
    Bryan SA; Jose PJ; Topping JR; Wilhelm R; Soderberg C; Kertesz D; Barnes PJ; Williams TJ; Hansel TT; Sabroe I
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1602-9. PubMed ID: 12070060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Ohno K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2009 Aug; 17(16):5989-6002. PubMed ID: 19620010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists.
    Runyon SP; Kormos CM; Gichinga MG; Mascarella SW; Navarro HA; Deschamps JR; Imler GH; Carroll FI
    J Org Chem; 2016 Nov; 81(21):10383-10391. PubMed ID: 27462910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.
    Nibbs RJ; Salcedo TW; Campbell JD; Yao XT; Li Y; Nardelli B; Olsen HS; Morris TS; Proudfoot AE; Patel VP; Graham GJ
    J Immunol; 2000 Feb; 164(3):1488-97. PubMed ID: 10640766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Hu Z; Clader JW; Greenlee W; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2247-50. PubMed ID: 11055330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecule antagonists for chemokine CCR3 receptors.
    Willems LI; Ijzerman AP
    Med Res Rev; 2010 Sep; 30(5):778-817. PubMed ID: 19967721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-amino-substituted analogues of 1-[(S)-2,4-diaminobutanoyl]piperidine as highly potent and selective dipeptidyl peptidase II inhibitors.
    Senten K; Van Der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
    J Med Chem; 2004 May; 47(11):2906-16. PubMed ID: 15139769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound.
    Forbes IT; Cooper DG; Dodds EK; Hickey DM; Ife RJ; Meeson M; Stockley M; Berkhout TA; Gohil J; Groot PH; Moores K
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1803-6. PubMed ID: 10969972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine Receptors and Drug Discovery--SMR meeting. 11 March 2004, Horsham, UK.
    Bhalay G; Dunstan A
    IDrugs; 2004 May; 7(5):441-3. PubMed ID: 15154104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.